Skip to content

HHRI News & Press Releases

HHRI News & Press Releases

Doxycycline

Doxycycline prophylaxis use low and did not prevent STIs among cisgender women

December 21, 2023

Researchers from the University of Washington (UW), Kenya Medical Research Institute (KEMRI), and Hennepin Healthcare Research Institute (HHRI) published results in the New England Journal of Medicine. The results of the study have been highly anticipated, as this is the first study of doxycycline PEP among cisgender women, following multiple…

Read More
Doxycycline

Doxycycline does not prevent STIs among cisgender women

February 20, 2023

Researchers from the University of Washington (UW), Kenya Medical Research Institute (KEMRI), and Hennepin Healthcare Research Institute (HHRI) announced results at CROI from a clinical trial demonstrating that doxycycline taken after sex does not prevent bacterial sexually transmitted infections (STIs) – chlamydia or gonorrhea – among cisgender women. The dPEP…

Read More
input search string and hit enter